|
U.S. Senate votes to reauthorize FDA user fees
 June 26, 2012 -- The U.S. Senate has passed the Food and Drug Administration Safety and Innovation Act by a vote of 92-4, and the bill, which reauthorizes the medical device user fee program for five years, is expected to be signed into law soon by President Obama.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
The U.S. House of Representatives passed the legislation last week; when enacted, it will authorize the FDA to collect user fees from industry to fund the review of innovator drugs, medical devices, generic drugs, and biosimilar biologics, according to the FDA.
The Medical Imaging and Technology Alliance (MITA) said it applauded the bipartisan efforts of the House and Senate to reauthorize the program, which secures employment for thousands of Americans and brings more devices to market in a timely manner, according to the organization. | |
|